Editor-in-ChiefProfessor Sobha Sivaprasad  Dr Sivaprasad is a Consultant Ophthalmologist at NIHR Moorfields Biomedical Research Centre, London, UK. She completed her Medical Retina Fellowship from Moorfields Eye Hospital. Her higher research degree from Cranfield University and King's College Hospital is on ‘Co-morbidity of age related macular degeneration and atherosclerosis’.
Dr Sivaprasad has active clinical and laboratory research interests in age related macular degeneration, diabetic retinopathy and retinal vascular disorders. Her research focuses on biomarkers and modeling of retinal morphology in retinal diseases.
She also runs several clinical trials in these areas and has over 100 peer reviewed publications to her credit.
Associate EditorsTin Aung, Singapore  MBBS (Singapore), FRCS(Ed), FRCOphth (UK), MMed (Ophth) (Singapore), FAM (Singapore), PhD (London)
Professor Aung is currently:
1. Executive Director, Singapore Eye Research Institute;
2. Deputy Medical Director (Research) and Head, Glaucoma Department, Singapore National Eye Centre;
3. Professor, Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore
Professor Aung is a clinician scientist, with clinical practice focusing on glaucoma and research interests in angle closure glaucoma and glaucoma genetics. With >450 publications, Professor Aung has been awarded >US$20 million in competitive research grant funding. He has received numerous awards including the Singapore Translational Research (STaR) Investigator Award in 2014, the Singapore National Medical Research Council-Clinician Scientist Awards in 2005 and 2008, the President's Science Award in 2009, the Nakajima (2007) and De Campo Awards (2013) from the Asia Pacific Academy of Ophthalmology and the Alcon Research Institute Award in 2013.
Professor Aung is a member of the Editorial Boards of Ophthalmology, Journal of Glaucoma, Eye, Graefe's Archive for Clinical and Experimental Ophthalmology, and 6 other journals. He is currently President of the World Glaucoma Association and also serves as a Board member of the Asia-Pacific Glaucoma Society and the Asian Angle Closure Glaucoma Club. Christopher Brand, UK David (Ted) Garway-Heath, UK  David Garway-Heath is President of the European Glaucoma Society, Vice President of the Imaging and Perimetry Society, and Chair of the Membership Committee of the Glaucoma Research Society. He is one of only few Senior Investigators in Ophthalmology of the UK National Institute for Health Research.
In addition to his clinical work, Professor Garway-Heath leads research in visual assessment and imaging at the Biomedical Research Centre of the UK National Institute for Health Research (NIHR). His research focuses on the development and evaluation of the techniques for effective diagnosis, monitoring and management of glaucoma, the identification of risk factors for glaucoma progression, and decision-support systems for healthcare delivery services. His work has contributed to the understanding of structure-function relationship in glaucoma, and his pioneering work in imaging has contributed to an ever-increasing use of the technique in glaucoma management. Professor Garway-Heath conducted the first randomized placebo-controlled trial to show visual field preservation in glaucoma patients with an IOP-lowering drug. The findings reported in The Lancet indicated that the study design enabled a considerable reduction in the period needed to identify treatment effects, thus increasing the likelihood of bringing new drugs more quickly and more cost-effectively to patients.
Parwez Hossain, UK  Parwez Hossain is King James IV Professor of Surgery (Royal College of Surgeons, Edinburgh) and Associate Professor in Ophthalmology at the University of Southampton.
Parwez qualified in Medicine from Aberdeen University and trained in Ophthalmology in Aberdeen, Nottingham, Leicester & Bascom Palmer Eye Institute, Miami, USA. He sub-specializes in Cornea & External Eye Disease, and is head of the corneal service for the Southampton Eye Unit, Southampton University Hospital NHS Foundation Trust, takes care of a diverse range of corneal diseases with patients coming from different regions of the UK.
Parwez's clinician-scientist career started as Wellcome Trust Fellow at Aberdeen University where he studied the mechanisms of lymphocyte traffic in ocular inflammation. In his PhD thesis, he established a novel method for in vivo tracking of immune cells in the posterior segment of the eye. The technique allowed the observation of lymphocytes and inflamed vascular endothelium, in real-time.
Following his PhD, Parwez moved to Nottingham University, where, as a Clinical Lecturer, his interest focused on investigating the innate immune mechanisms in corneal inflammation. He determined that the immune adhesion molecule CD34 is a unique marker for human corneal stromal keratocytes (corneal fibroblast) activation. Whilst at Nottingham, he also helped to establish the effectiveness of a new surgical technique called 'Fine Needle Diathermy' to treat long standing corneal vascularization. This treatment helps against chronic corneal vascularization and can restore vision in patients with vascularisation from herpes keratitis or chronic corneal graft rejection. Parwez also developed techniques in corneal confocal imaging and his work has highlighted the benefit of this in the early detection of diabetic peripheral neuropathy (published in The Lancet).
After his fellowship training period, Parwez moved to Southampton, to start a research programme in corneal infection. In his current role, he leads a corneal infection research group comprising a post-doctoral fellow, PhD & undergraduate research students. His research focus is to develop new diagnostic techniques for the rapid diagnosis and monitoring of corneal infections. His group have developed technologies such as anterior segment OCT & microfluidic impedance cytometry to allow rapid microbial diagnostic detection/monitoring.
With collaboration with his surgical colleagues in Southampton, Parwez has developed an active surgical research programme with the aim to develop optimal surgical methods for corneal diseases. Developing method such as ultrathin DSEK and accelerated protocols for collagen cross-linking for Keratoconus. His surgical team are part of the UK Collagen Cross-linking Consortium and are major providers for collagen crosslinking therapy for the South Coast of the UK.
In 2018, Parwez was awarded King James IV Professor in Surgery by The Royal College of Surgeons, Edinburgh for his sustained research in the development of real-time diagnostic methods/devices in Ophthalmology.
His work has been supported by research grants from the Royal College of Surgeons of Edinburgh, the British Council for the Prevention for Blindness, National Eye Research Centre, Engineering & Physicals Sciences Research Council (UK) and Medical Research Council (UK).
Timothy Y Y Lai, China  Dr Lai is an Honorary Clinical Associate Professor of the Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, and Director of 2010 Retina and Macula Centre, Hong Kong. His clinical and research interests lie in the medical and surgical management of retinal diseases, particularly polypoidal choroidal vasculopathy, choroidal neovascularization, central serous chorioretinopathy, myopic maculopathy, diabetic retinopathy; visual electrophysiology; and genetics of retinal diseases and uveitis. He has extensive experience in the conduct of clinical trials and is the principle investigator of over 15 industry-sponsored Phase II, III and IV clinical trials.
As one of the leading experts in vitreo-retinal diseases in the Asia-Pacific region, Dr Lai has published more than 180 papers in international peer-reviewed journals and co-authored and edited 10 textbooks. He has also delivered over 120 invited lectures worldwide and has received a number of
Andrew Lee, USA  Andrew G Lee, M.D. is an honors graduate of the University of Virginia undergraduate school and an Alpha Omega Alpha graduate of the UVA School of Medicine. He completed his ophthalmology residency and was the chief resident at Baylor College of Medicine in Houston, Texas in 1993. Following eye residency, Dr Lee completed a clinical fellowship in neuro-ophthalmology with Neil R. Miller MD at the Wilmer Eye Institute and was a post-doctoral Fight for Sight research fellow at the Johns Hopkins Hospital in Baltimore, Maryland from 1993-1994. He was an Associate Professor at Baylor College of Medicine and Adjunct Associate Professor at the M.D. Anderson Cancer Center in Houston from 1994-2000. From 2000-2008, Dr Lee was Professor of Ophthalmology, Neurology, and Neurosurgery in the H. Stanley Thompson Neuro-ophthalmology Clinic at the University of Iowa Hospitals and Clinics. In April 2009 Dr Lee assumed the chairmanship of ophthalmology at The Blanton Eye Institute, at Houston Methodist Hospital in Texas and was appointed Professor of Ophthalmology, Neurological Surgery and Neurology at Weill Cornell Medical College.
Dr Lee has published over 260 peer-reviewed articles, 40 book chapters, and three full textbooks in ophthalmology. He serves on the Editorial Board of 12 journals including the American Journal of Ophthalmology, the Canadian Journal of Ophthalmology, and Eye. He has received the American Academy of Ophthalmology (AAO) Honor Award, the AAO Secretariat Award, and the AAO Senior Achievement Award. Dr Lee has been the invited guest speaker at over 140 national and international eye meetings.
Dr Lee’s area of research interest is in optic nerve disease. He was the Director of New Educational Initiatives in the Graduate Medical Education (GME) office at Iowa and has published extensively in the area of resident graduate medical education. In April 2009 Dr Lee assumed the chairmanship of ophthalmology at The Methodist Hospital in Houston, Texas and was appointed Professor of Ophthalmology, Neurological Surgery and Neurology at Weill Cornell Medical College.
Caroline J MacEwen, UK  Caroline (Carrie) MacEwen is a Consultant Ophthalmologist at Ninewells Hospital and Medical School and Head of the Ophthalmology Department at the University of Dundee (Honorary Professor). She trained in Glasgow, Dundee and London. Her clinical interests lie in the field of strabismus and ocular motility after carrying out her subspecialty training at Moorfields Eye Hospital under the guidance of John Lee. Research interests include paediatric naso -lacrimal disease, trauma, sports medicine, epidemiology and clinical research on strabismus management. She has been a member of the British Ophthalmic Surveillance Unit (BOSU) committee since its inception. International and national awards for her work include the Gregg medal for ‘contribution to medical science’, the Founder's Cup, Ian Fraser trophy, Spencer Walker prize and Foulds' trophy. She has published more than 150 papers, written or edited 3 textbooks and written 17 book chapters. Carrie is an associate postgraduate Dean in the East of Scotland.
She is Chair of the Academy of Medical Royal Colleges (2017–2020) and was President of the Royal College of Ophthalmologists (2014 – 2017). She represented the RCOphth in the development of the Faculty of Sport and Exercise Medicine (FSEM)
She is ophthalmology clinical co-lead for the Getting It Right First Time (GIRFT) project, was a member of the Right Care Clinical Improvement Group and chaired the Elective Care Transformation Ophthalmology Working Group.
She is Ophthalmology Specialty Adviser to the Scottish Government and leads the National Ophthalmology Workstream in Scotland and is a member of the National Access Collaborative. Professor MacEwen chaired the Scottish update of Certification of Vision Impairment and was a member of the UKCVI development board, the UK Vision Strategy Leadership Group and Transition Programme Board.
Carrie has worked nationally with all eye health care professionals to share and develop new ways of delivering ophthalmic care and has delivered a framework to support this. She has been made an honorary fellow of the College of Optometrists and the British and Irish Orthoptic Society, the Faculty of Sport and Exercise Medicine and the Royal College of Physicians, Edinburgh
Hunter MacLean, UK  Hunter Maclean is a Consultant Ophthalmologist at the Queen Alexandra Eye Hospital Portsmouth, in the south of England. He specialises in oculoplastics and lacrimal surgery. He received his medical degree from Edinburgh University and did further training there and at Newcastle with a fellowship in Sydney, Australia before taking up his consultant post in 1998. He was a founding member of the British Oculoplastic surgical society and takes an active part in research within the department and is also the current President of the Southern Ophthalmological Society. He has written one book and contributed several chapters in others. He was appointed Associate Editor of Eye in 2009.
Saaeha Rauz,UK David Steel, UK  David Steel is a Consultant Ophthalmologist and Vitreo-retinal surgeon at Sunderland Eye Infirmary and Honorary Senior Lecturer at the Institute of Genetic Medicine at Newcastle University, in the North East of England. He graduated in Medicine at Newcastle in 1989 and completed his initial training posts at Sunderland and Newcastle before registrar posts at Bristol, Torbay and Bath. He undertook sub specialty training in retinal surgery at the Royal Victorian Eye and Ear Hospital, Melbourne and was appointed Consultant at Sunderland in 1999. David leads the medical and surgical retinal service at the Eye Infirmary and the units expanding clinical trials unit. He has research interest in many aspects of retinal disease and was co-founder of the Newcastle University retinal stem cell group (http://www.retinalstemcellresearch.co.uk). He has published approximately 140 peer reviewed publications with ~2900 citations, and was named as the NIHR and Royal College of Ophthalmologists Researcher of the year in 2018. He is an associate Editor for the Journal Eye, and on the editorial board of Graefe's Archive for Clinical and Experimental Ophthalmology and the ASRS’s Journal of Vitreo-Retinal Diseases. He has been a board member of the British and Eire Association of Vitreoretinal Surgeons since 2009 and the British Ophthalmic surveillance unit since 2014. He is an elected member of the British Eye Study group and the Club Jules Gonin, and has been an invited Guest speaker at several National and International retinal societies.
Rupal H Trivedi, USA  Dr Trivedi is a Research Associate Professor at Storm Eye Institute, Medical University of South Carolina, USA. She completed her residency in Ophthalmology from India in 1995. From 1995 to 2000, she worked at Iladevi cataract and IOL research center, India. She received her Master of Science in Clinical Research (MSCR) degree from Medical University of South Carolina. Dr Trivedi's research interests include cataract surgery, especially for children. She has published more than 100 articles in peer-reviewed journals and presented her research work at various national and international meetings. She is recipient of various awards including ASCRS foundation Binkhorst young ophthalmologist award, American Academy of Ophthalmology Achievement Award, RCMAR scholar award and Clinical Research Curriculum Award.
Editorial AssistantSteve Beet, UK
|
京公网安备 11010802027423号